hsa_circ_0000518 stimulates the malignant progression of hepatocellular carcinoma via regulating ITGA5 to activate the Warburg effect
- PMID: 38830562
- DOI: 10.1016/j.cellsig.2024.111243
hsa_circ_0000518 stimulates the malignant progression of hepatocellular carcinoma via regulating ITGA5 to activate the Warburg effect
Abstract
Studies have shown that the abnormal expression of circular RNA (circRNA) is inextricably linked to hepatocellular carcinoma (HCC). Recently, hsa_circ_0000518 (circ_0000518) was discovered in many cancer progressions. However, its function in HCC is still unclear. Through GEO database analysis combined with gene expression detection of HCC related clinical samples and cell lines, we identified that circ_0000518 was abnormally overexpressed in HCC. Cell and animal model experiments jointly indicated that circ_0000518 can stimulate HCC cell proliferation, migration, invasion and suppress apoptosis. Furthermore, we also found that knocking down the circ_0000518 could inhibit the Warburg effect in HCC cells. Mechanistically, circ_0000518 was found to be primarily localized in the cytoplasm, and sponge hsa-miR-326 (miR-326) promoted integrin alpha 5 (ITGA5) expression. In addition, circ_0000518 could enhance the stability of HuR-mediated ITGA5 mRNA, thereby activating the Warburg effect. In conclusion, this study elucidated that circ_0000518 was a cancer-promoting circRNA, which could enhance ITGA5 expression through competing endogenous RNAs (ceRNA) and RNA Binding Protein (RBP) mechanisms, thus facilitating the development of HCC. It provides a meaningful diagnostic and therapeutic target for HCC.
Keywords: HCC; HuR; ITGA5; circ_0000518; miR-326.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Hsa_circ_0088036 promotes tumorigenesis and chemotherapy resistance in hepatocellular carcinoma via the miR-140-3p/KIF2A axis.Histol Histopathol. 2025 Aug;40(8):1239-1251. doi: 10.14670/HH-18-849. Epub 2024 Nov 19. Histol Histopathol. 2025. PMID: 39587911
-
Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission.Apoptosis. 2024 Jun;29(5-6):709-725. doi: 10.1007/s10495-023-01903-8. Epub 2024 Mar 8. Apoptosis. 2024. PMID: 38459420
-
Hsa_circ_0011946 promotes the migration and invasion of hepatocellular carcinoma by inducing EMT process.Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1108-1115. doi: 10.26355/eurrev_202002_20161. Eur Rev Med Pharmacol Sci. 2020. PMID: 32096173
-
Circ_0008043 promotes the metastasis of hepatocellular carcinoma by regulating the miR-661/PLEKHG4B axis.Sci Rep. 2025 Jul 8;15(1):24580. doi: 10.1038/s41598-025-10618-6. Sci Rep. 2025. PMID: 40628993 Free PMC article.
-
The Protective Role of miR-125b in Hepatocellular Carcinoma: Unraveling Tumor-Suppressive Mechanisms.Curr Mol Med. 2025;25(6):663-671. doi: 10.2174/0115665240304247240529074123. Curr Mol Med. 2025. PMID: 38859784 Review.
Cited by
-
Migrasome-related ITGA5 for predicting prognosis, immune infiltration and drug sensitivity of hepatocellular carcinoma.Apoptosis. 2025 Jun;30(5-6):1424-1439. doi: 10.1007/s10495-025-02103-2. Epub 2025 Mar 27. Apoptosis. 2025. PMID: 40146484
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous